Key Takeaways
- Always consult your veterinarian before combining EMS supplements with prescription medications to avoid dangerous interactions that can harm your horse’s kidneys, liver, or overall health
- Chasteberry significantly interferes with pergolide effectiveness, reducing ACTH control by competing for the same dopamine receptors in horses with both EMS and PPID
- SGLT2 inhibitors like ertugliflozin combined with NSAIDs dramatically increase acute kidney failure risk and require immediate NSAID discontinuation
- Metformin has only 4-7% bioavailability in horses, making it largely ineffective for systemic insulin control but potentially helpful when given 30 minutes before feeding
- Levothyroxine requires strict concurrent diet restriction to work effectively and must be tapered gradually over four weeks to prevent dangerous metabolic rebound
Understanding EMS Supplement-Medication Safety
When you’re managing Equine Metabolic Syndrome in your horse, combining supplements with prescription medications isn’t as simple as adding ingredients to a recipe. Some combinations can block each other’s effects, while others create serious health risks that could land your horse in an emergency situation. Your horse’s safety depends on understanding which supplements and medications work together—and which ones absolutely don’t.

This guide walks you through the most critical drug interactions horse owners face when managing EMS, so you can make informed decisions that protect your horse while maximizing treatment effectiveness.
Why Drug Interactions Matter for EMS Horses
EMS horses often need multiple therapies working simultaneously. You might be using chasteberry for early PPID symptoms, chromium for insulin support, and prescription medications like pergolide or levothyroxine. Each substance affects how your horse’s body processes the others.
Research shows that certain supplement combinations can interfere with prescription medications, potentially leaving hormones uncontrolled even when you think your horse is properly medicated.[1] The stakes are high: uncontrolled insulin levels mean laminitis risk, while kidney damage from drug interactions can become permanent.
Your veterinarian needs to know every single supplement your horse receives. Keep a written list updated with exact products, doses, and timing. This isn’t just good practice—it’s essential for preventing interactions that could compromise your horse’s treatment or health.
The Chasteberry-Pergolide Conflict You Need to Know
How This Interaction Happens
If your horse has both EMS and PPID (Cushing’s disease), you might be tempted to use chasteberry alongside pergolide. Don’t. Studies confirm that chasteberry directly interferes with pergolide’s ability to control ACTH levels because both substances compete for the same dopamine receptor binding sites in the brain.[1]
Horses receiving both chasteberry and pergolide showed much higher ACTH levels than horses on pergolide alone, with the interference becoming particularly obvious during seasonal ACTH rises.[1] Your horse might look better coat-wise, but the underlying pituitary tumor continues growing unchecked.
What This Means for Your Horse
Pergolide remains the gold standard PPID treatment because it actually controls abnormal hormone output from the pituitary gland. Chasteberry has never been documented to control pituitary hormone output, and now evidence shows it may block pergolide’s effectiveness.[3]
If your horse is on pergolide, skip the chasteberry completely. If you’ve been using chasteberry and need to start pergolide, work with your vet to transition safely. The improved coat condition from chasteberry isn’t worth risking uncontrolled PPID progression.
Expert Perspective
According to Dr. Eleanor Kellon, who first published research on chasteberry use in PPID horses, “The bottom line here is that chasteberry alone is not an adequate treatment for PPID. Symptoms may improve for a while but the abnormal growth in the pituitary goes unchecked and when chasteberry stops working the process is much more difficult to get under control.”[1]
SGLT2 Inhibitors and NSAIDs: A Dangerous Kidney Combination
Understanding the Kidney Risk
SGLT2 inhibitors (ertugliflozin, canagliflozin) represent breakthrough treatments for refractory insulin resistance in EMS horses. However, combining these medications with NSAIDs creates a perfect storm for acute kidney injury.
Ertugliflozin increases the risk of renal failure when administered concurrently with nonsteroidal anti-inflammatory drugs like phenylbutazone or firocoxib.[5] The mechanism involves multiple factors: SGLT2 inhibitors cause mild dehydration through glucose excretion in urine, while NSAIDs reduce kidney blood flow. Together, they can trigger acute kidney damage.
Clinical Reality and Solutions
In a retrospective study of 51 horses with hyperinsulinemia-associated laminitis treated with ertugliflozin, the drug allowed stopping NSAID treatment in almost all cases within 2 weeks as laminitis pain improved.[6] This creates a natural solution: the SGLT2 inhibitor reduces laminitis pain so effectively that NSAIDs become unnecessary.
If your horse is starting an SGLT2 inhibitor:
- Discontinue NSAIDs immediately unless your vet determines they’re absolutely essential
- Ensure unlimited access to fresh water
- Provide guaranteed salt intake to prevent dehydration
- Schedule bloodwork to monitor kidney function (BUN, creatinine) and triglyceride levels
Horses must be screened for renal function before starting SGLT2 inhibitors, and the increased risk with concurrent NSAID use means these drugs should not be combined in laminitis cases.[7]
Levothyroxine: Not a Standalone Solution
The Diet Dependency
Many horse owners view levothyroxine as a “weight loss pill” for their EMS horses. It’s not that simple. Research clearly shows that levothyroxine induces weight loss and reduces neck circumference in EMS horses when animals are kept on a weight maintenance diet, but does not influence glucose dynamics or insulin sensitivity.[11]
Translation: Levothyroxine won’t fix your horse’s insulin problems. It works by increasing metabolic rate, which burns more calories—but only if you’re simultaneously restricting calorie intake. Feed your horse ad libitum hay while on levothyroxine, and you’ll simply have a horse eating more to match the increased metabolism.
Safe Levothyroxine Use Protocol
Levothyroxine treatment should be administered at 0.1-0.15 mg/kg levothyroxine sodium once daily orally until an appropriate body condition is attained or for a maximum of 6 months.[13] For a 500kg horse, that’s 48-72mg daily.
Critical tapering requirement: Horses must be weaned off levothyroxine at the end of the treatment period by decreasing the dose by half for 2 weeks and then a quarter for 2 weeks.[13] Sudden discontinuation can trigger metabolic rebound that puts your horse at risk for laminitis.
When to Consider Levothyroxine
Levothyroxine makes sense for “weight-loss resistant” horses—those who remain obese despite strict diet and exercise for 30+ days. It accelerates fat loss in these frustrating cases, but you must maintain dietary restriction throughout treatment and beyond.
Metformin: Understanding Its Limited Role
The Bioavailability Problem
Metformin seems like it should work brilliantly for EMS horses. In humans, it’s a diabetes management cornerstone. In horses, there’s a massive problem: bioavailability was determined to be approximately 7.1% in unfed horses and 3.9% in fed horses.[15]
Less than 8% of the metformin you give your horse actually gets absorbed into the bloodstream. This explains why metformin does not have systemic effects on insulin sensitivity in horses despite having some benefit on reducing post-meal insulin spikes.[13,16]
How Metformin Actually Works in Horses
Instead of systemic effects, metformin has a direct effect on the enterocyte (intestinal cells) and decreases enteric glucose absorption, consequently reducing the insulin response to oral glucose in horses.[13] It works locally in the gut, not systemically like in humans.
Practical application: Give metformin 30-60 minutes before feeding to maximize its gut-level effect on blocking glucose absorption. Response to metformin can be evaluated by performing an oral sugar test 30-60 minutes after drug administration to assess benefits in the individual patient.[13]
Quick Reference: Critical EMS Supplement-Medication Interactions
| Supplement/Medication | Interacts With | Risk Level | What Happens | Action Required |
|---|---|---|---|---|
| Chasteberry | Pergolide (Prascend) | HIGH | Blocks pergolide effectiveness; ACTH stays elevated | Choose one or the other – never combine |
| SGLT2 Inhibitors (Ertugliflozin, Canagliflozin) | NSAIDs (Bute, Firocoxib, Flunixin) | HIGH | Dramatically increases acute kidney injury risk | Stop NSAIDs when starting SGLT2i; monitor kidney function closely |
| Levothyroxine | High-calorie diet | MEDIUM | Ineffective for weight loss without diet restriction | Must combine with strict calorie control |
| Metformin | N/A (poor absorption) | LOW | Limited systemic effects; works locally in gut | Give 30-60 min before feeding for best results |
| Chromium/Magnesium | Various medications | LOW | Generally safe but limited efficacy evidence | Inform vet; not reliable as sole treatment |
Supplement Timing Strategies to Avoid Interactions
Create a Medication Schedule
Write out your horse’s complete medication and supplement schedule hour by hour. Some combinations work fine if separated by 2-4 hours, even if they shouldn’t be given simultaneously.
Sample safe timing protocol:
- 7:00 AM: Pergolide with morning feed
- 7:30 AM: Chromium and magnesium supplements
- 11:00 AM: Metformin (30 minutes before lunch hay)
- 11:30 AM: Lunch hay
- 4:30 PM: Metformin (30 minutes before dinner)
- 5:00 PM: Dinner with levothyroxine and balancer
- 10:00 PM: Late-night hay
Monitor and Document
Keep a log of:
- All supplements with exact brand names and doses
- Prescription medications and timing
- Any changes in behavior, appetite, or hoof comfort
- Scheduled bloodwork results
Share this log with your veterinarian at every visit. Patterns often emerge that help fine-tune your horse’s protocol.
When to Call Your Veterinarian Immediately
Watch for these red flags that indicate a potential drug interaction or adverse reaction:
Kidney-related warnings:
- Decreased urination or very dark urine
- Swelling in lower legs
- Loss of appetite
- Depression or lethargy
Metabolic crisis signs:
- Sudden onset or worsening lameness
- Increased digital pulses
- Reluctance to move
- Lying down more than normal
Thyroid oversupplementation:
- Excessive sweating
- Rapid heart rate (>48 bpm at rest)
- Anxiety or nervousness
- Rapid weight loss with good appetite
Monitoring Requirements for Common EMS Medication Combinations
| Medication/Supplement | Recommended Monitoring | Frequency | Key Parameters |
|---|---|---|---|
| SGLT2 Inhibitors | Blood chemistry panel | Every 2-4 weeks initially, then monthly | BUN, creatinine, triglycerides, liver enzymes |
| Pergolide | ACTH testing | 6-8 weeks after dose changes; seasonally | ACTH levels, clinical signs improvement |
| Levothyroxine | Body condition scoring, insulin testing | Monthly BCS; insulin test every 6-8 weeks | Weight loss rate, resting insulin, T4 levels |
| Metformin | Post-prandial insulin test | 2-4 weeks after starting | Insulin 2 hours after feeding |
| Chromium | Insulin dynamics | 8-12 weeks after starting | Oral sugar test or resting insulin |
Building Your Veterinary Partnership
Information Your Vet Needs
Come to appointments prepared with:
- Complete list of current supplements (brands, doses, timing)
- All prescription medications
- Recent changes in management or diet
- Photos or videos of any concerning symptoms
- Questions written down in advance
Questions to Ask Your Vet
- “Are there any interactions between [supplement X] and [medication Y]?”
- “What signs should I watch for that indicate a problem?”
- “How will we monitor whether this combination is working?”
- “What’s our backup plan if this approach doesn’t work?”
- “Should we adjust timing to minimize interactions?”
The Role of Supplements vs. Medications in EMS Management
Medications: Targeted Hormonal Control
Prescription medications like pergolide, SGLT2 inhibitors, and levothyroxine directly modify hormone levels or metabolic rate. They’re powerful tools with specific indications and require veterinary monitoring.
Supplements: Supporting Nutritional Needs
Chromium, magnesium, antioxidants, and similar supplements provide nutritional support. While evidence for chromium and magnesium improving insulin sensitivity in horses is limited from experimental studies, they’re generally safe at recommended doses. Don’t rely on supplements alone to manage EMS—they’re supportive, not curative.
The foundation remains diet and exercise. No medication or supplement substitutes for proper calorie control, low-NSC forage, and appropriate exercise. Everything else enhances these fundamentals but can’t replace them.
Special Considerations for Horses with Multiple Conditions
EMS + PPID Combination
Older horses often have both conditions. When PPID has been diagnosed, pergolide treatment is recommended to minimize the effects of PPID on insulin dysregulation.[13] Control the PPID first with pergolide alone, then address remaining insulin issues with appropriate EMS management.
EMS + Active Laminitis
During acute laminitis episodes, pain control becomes crucial. However, SGLT2 inhibitor treatment often eliminates the need for NSAIDs within 2 weeks as insulin-driven inflammation resolves.[6] Work with your vet to minimize NSAID duration while the SGLT2 inhibitor takes effect.
Weight-Loss Resistant Cases
Some horses stay obese despite perfect diet management. These frustrating cases benefit from levothyroxine at 0.1 mg/kg daily for 3-6 months to accelerate fat loss, but only when combined with continued dietary restriction.[14] Don’t expect magic—levothyroxine amplifies diet efforts but doesn’t replace them.
Conclusion
Managing EMS medications and supplements safely requires knowledge, vigilance, and close veterinary partnership. The most dangerous assumption you can make is that “natural” supplements are automatically safe to combine with prescriptions. Chasteberry blocking pergolide and NSAIDs damaging kidneys when combined with SGLT2 inhibitors prove that interactions matter enormously.
Start by listing every single supplement and medication your horse receives. Review this list with your veterinarian and create a timing strategy that maximizes benefits while minimizing risks. Monitor your horse closely for any changes, and don’t hesitate to call your vet if something seems off.
Your horse’s safety depends on informed decision-making. With the right knowledge and veterinary support, you can navigate the complex world of EMS medications and supplements confidently, giving your horse the best chance at metabolic stability and freedom from laminitis.
EMS Supplement Medication Interactions FAQs
Can I give my EMS horse chasteberry if he’s on pergolide for Cushing’s?
No, you should not combine chasteberry with pergolide. Research shows that chasteberry interferes with pergolide’s effectiveness by competing for the same dopamine receptors, resulting in higher ACTH levels even though clinical symptoms like coat quality may improve.[1] Choose pergolide for PPID control and skip the chasteberry.
Is it safe to use bute with ems supplement medication interactions like SGLT2 inhibitors?
Combining NSAIDs like phenylbutazone with SGLT2 inhibitors dramatically increases the risk of acute kidney failure.[5] Fortunately, most horses can discontinue NSAIDs within 2 weeks of starting SGLT2 inhibitor treatment as laminitis pain resolves.[6] Always inform your vet if your horse needs both classes of drugs simultaneously.
Why isn’t metformin working for my horse’s insulin levels?
Metformin has very poor bioavailability in horses at only 3.9-7.1%, meaning most of the drug never enters the bloodstream.[15] Instead, metformin works locally in the intestinal tract to decrease glucose absorption rather than having systemic effects on insulin sensitivity.[13] Give it 30-60 minutes before feeding for best results, but don’t expect dramatic insulin improvements.
How long can my EMS horse stay on levothyroxine safely?
Levothyroxine should be used for a maximum of 6 months to accelerate weight loss, then gradually tapered by reducing the dose by half for 2 weeks, then by a quarter for another 2 weeks before stopping.[13] Never stop levothyroxine abruptly, especially in horses at risk for laminitis, as this can trigger dangerous metabolic rebound.
Do chromium and magnesium supplements interact with EMS medications?
Chromium and magnesium supplements are generally safe to use alongside EMS medications without major interactions. However, evidence supporting their efficacy for improving insulin sensitivity in horses remains limited from experimental studies, so they should not be relied upon as primary treatment and your veterinarian should be informed of their use.
EMS Supplement Medication Interactions Citations
- Warning to Horse Owners: Use Caution Mixing Chastetree Berries with Pergolide – EquiMed
- Treating PPID: the pill or the plant? – Understanding Laminitis
- Mixing Chastetree Berries With Pergolide in Cushing’s Horses – Dr. K’s Horse Sense
- Prascend® (Pergolide) for Horses with PPID – Mad Barn
- Ertugliflozin for Horses – Wedgewood Pharmacy
- Sodium-glucose cotransporter 2 inhibitors in horses – Mad Barn
- Use of SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia – PMC
- NSAIDs With SGLT2 Inhibitors May Cause Renal Injury – Medscape
- Integrating SGLT2is into Management of Equine Metabolic Syndrome – The Horse
- Thyroid Hormones May Benefit Metabolic Horses – Kentucky Equine Research
- Thyroid Hormone and Equine Metabolic Syndrome – EquiMed
- Thyroid Hormone Supplementation Levothyroxine Sodium – Horse Side Vet Guide
- ECEIM consensus statement on equine metabolic syndrome – PMC
- Equine Metabolic Syndrome – Merck Veterinary Manual
- Pharmacokinetics and bioavailability of metformin in horses – AJVR
- Effects of metformin hydrochloride on blood glucose and insulin – Equine Veterinary Journal






Leave a Reply